Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022

NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire

Spreading safe, cheap embolization around the world

Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice


Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.


CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.


Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.

Dernières Publications (5/0)

  1. Horowitz, T, Tabouret, E, Graillon, T, Salgues, B, Chinot, O, Verger, A et al.. Contribution of nuclear medicine to the diagnosis and management of primary brain tumours. Rev Neurol (Paris). 2023; :. doi: 10.1016/j.neurol.2023.03.002. PubMed PMID:36934021 .
  2. Ayari, S, Abellard, A, Carayol, M, Guedj, É, Gavarry, O. A systematic review of exercise modalities that reduce pro-inflammatory cytokines in humans and animals’ models with mild cognitive impairment or dementia. Exp Gerontol. 2023;175 :112141. doi: 10.1016/j.exger.2023.112141. PubMed PMID:36898593 .
  3. Verger, A, Yakushev, I, Albert, NL, van Berckel, B, Brendel, M, Cecchin, D et al.. FDA approval of lecanemab: the real start of widespread amyloid PET use? – the EANM Neuroimaging Committee perspective. Eur J Nucl Med Mol Imaging. 2023; :. doi: 10.1007/s00259-023-06177-5. PubMed PMID:36869178 .
  4. Horowitz, T, Doche, E, Philip, M, Cammilleri, S, Suissa, L, Guedj, E et al.. Regional brain glucose metabolism is differentially affected by ketogenic diet: a human semiquantitative positron emission tomography. Eur J Nucl Med Mol Imaging. 2023; :. doi: 10.1007/s00259-023-06156-w. PubMed PMID:36867201 .
  5. Imperiale, A, Jha, A, Meuter, L, Nicolas, GP, Taïeb, D, Pacak, K et al.. The emergence of somatostatin antagonist-based theranostics: Paving the road toward another success?. J Nucl Med. 2023; :. doi: 10.2967/jnumed.123.265406. PubMed PMID:36759198 .
Search PubMed